Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
Saved in:
| Title: | Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis? |
|---|---|
| Authors: | Mendoza, Maria Alejandra1 (AUTHOR) mendoza.maria3@mayo.edu, Bhaimia, Eric2 (AUTHOR), Alkhateeb, Hassan B.3 (AUTHOR), Razonable, Raymund R.1 (AUTHOR), Thoendel, Matthew1 (AUTHOR) |
| Source: | Transplant Infectious Disease. Dec2024, Vol. 26 Issue 6, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
